ClinicalTrials.gg
CompletedNCT05104255Updated Feb 20, 2024

Neonatal Outcomes in Twin Pregnancies

An observational study in Twin Pregnancy and Neonate, sponsored by Derince Training and Research Hospital. Completed. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by Derince Training and Research Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
527
Sex
All
01

Study summary

Multiple pregnancies are associated with increased maternal and fetal risks compared to singleton pregnancies. Additionally, the cesarean section rate is quite high in multiple pregnancies. This study aimed to evaluate maternal and fetal characteristics and factors affecting fetal outcomes in twin pregnancies delivered by cesarean section.

Read the detailed description

While the frequency of multiple pregnancies varies significantly among societies and individuals, especially in middle and high-income countries, the rate of multiple pregnancies has shown a significant rise worldwide in recent years, with the frequent use of assisted reproductive techniques, which has increased due to an increase in maternal age and a decrease in fertility. As a result, multiple pregnancies constitute approximately 2-4% of all births.

Multiple pregnancies are known to be associated with increased maternal and fetal risks compared to singleton pregnancies. While maternal mortality associated with a twin pregnancy is 2.5 times higher than in singleton pregnancy, adverse neonatal outcomes such as perinatal mortality, fetal growth restriction, and low birth weight are two to three times higher in twins than in singleton newborns. Moreover, neonatal near-miss, which refers to cases that almost resulted in death, is associated with multiple pregnancies.

For all these reasons, the planned cesarean section has been advocated over planned vaginal delivery to reduce the risk of adverse neonatal outcomes (especially for the second-born twin). However, cesarean delivery is known to be associated with a higher risk of maternal morbidity and poor neonatal outcomes. The vast majority of these risks are related to maternal hypotension, prolonged uterine-incision-to-delivery time, and general anesthesia. From this perspective, we aimed to evaluate maternal and fetal characteristics and factors affecting fetal outcomes in twin pregnancies delivered by cesarean section.

02

Conditions studied

  • Twin Pregnancy
  • Neonate

Keywords

  • General anesthesia
  • Neonate
  • Obstetric anesthesia
  • Pregnancy Outcomes
  • Spinal anesthesia
  • Twins
  • Twin pregnancy
03

In context

Lead sponsor

Derince Training and Research Hospital is the lead sponsor of 39 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The twin newborns were delivered by cesarean section.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Twin pregnancies
  • Parturients delivered by cesarean section

Exclusion criteria

Exclusion Criteria:

  • The triplets or more multiple pregnancies
  • Twins delivered through the vaginal route were excluded from the study.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
527 participants (actual)
Patient registry
No

Groups and cohorts

  • Twin neonates

    The demographic data and characteristics of the twins were evaluated.

    Procedure: Spinal anesthesia · Procedure: General anesthesia

Interventions

  • ProcedureSpinal anesthesia

    Twins delivered under under spinal anesthesia

  • ProcedureGeneral anesthesia

    Twins delivered under general anesthesia

06

What researchers measure

Primary outcomes

  1. Appearance-Pulse-Grimace-Activity-Respiration-1st minute (worst:0; best:10)

    Appearance-Pulse-Grimace-Activity-Respiration (APGAR) score at the 1st minute after delivery

    Time frame: 1 minute

  2. Appearance-Pulse-Grimace-Activity-Respiration-5th minute (worst:0; best:10)

    Appearance-Pulse-Grimace-Activity-Respiration (APGAR) score at the 5th minute after delivery

    Time frame: 5 minute

  3. The Number of Participants Admitted to Neonatal Intensive Care Unit

    Admission to Neonatal Intensive Care Unit after delivery

    Time frame: 1 hour

  4. The Number of Participants needed for Mechanical ventilation

    The need for non-invasive and invasive mechanical ventilation

    Time frame: 28 days

  5. The Rate of Death

    Neonatal mortality within the first 28 days after birth.

    Time frame: 28 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Young BC, Wylie BJ. Effects of twin gestation on maternal morbidity. Semin Perinatol. 2012 Jun;36(3):162-8. doi: 10.1053/j.semperi.2012.02.007. PubMed 22713496 ↗
  • Santana DS, Surita FG, Cecatti JG. Multiple Pregnancy: Epidemiology and Association with Maternal and Perinatal Morbidity. Rev Bras Ginecol Obstet. 2018 Sep;40(9):554-562. doi: 10.1055/s-0038-1668117. Epub 2018 Sep 19. PubMed 30231294 ↗
  • Cheong-See F, Schuit E, Arroyo-Manzano D, Khalil A, Barrett J, Joseph KS, Asztalos E, Hack K, Lewi L, Lim A, Liem S, Norman JE, Morrison J, Combs CA, Garite TJ, Maurel K, Serra V, Perales A, Rode L, Worda K, Nassar A, Aboulghar M, Rouse D, Thom E, Breathnach F, Nakayama S, Russo FM, Robinson JN, Dodd JM, Newman RB, Bhattacharya S, Tang S, Mol BW, Zamora J, Thilaganathan B, Thangaratinam S; Global Obstetrics Network (GONet) Collaboration. Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis. BMJ. 2016 Sep 6;354:i4353. doi: 10.1136/bmj.i4353. PubMed 27599496 ↗
  • National Collaborating Centre for Women's and Children's Health (UK). Multiple Pregnancy: The Management of Twin and Triplet Pregnancies in the Antenatal Period. London: RCOG Press; 2011 Sep. Available from http://www.ncbi.nlm.nih.gov/books/NBK83105/ PubMed 22855972 ↗

Individual participant data

Plan to share: Yes — Individual, de-identified participant data will be shared with the researchers who provide a methodologically sound proposal.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Beginning nine months following a possible publication and ending after one year.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2017 to primary completion in Jan 2020, 36 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2021
First posted
Nov 2, 2021
StartActual
Jan 1, 2017
Primary completionActual
Jan 31, 2020
CompletionActual
Feb 1, 2020
Last update
Feb 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05104255
Lead sponsor
Derince Training and Research Hospital
Collaborators
Bursa Yüksek İhtisas Education and Research Hospital
Responsible party
Hande Gurbuz (Medical Doctor, Associate Professor, Principal Investigator, Bursa Yüksek İhtisas Education and Research Hospital) — Principal investigator
First posted
Nov 2, 2021
Start date
Jan 1, 2017
Primary completion
Jan 31, 2020
Completion
Feb 1, 2020
Last update
Feb 20, 2024

Study contacts

Hande Gurbuz, Assoc. Prof.
study director · Bursa Yuksek Ihtisas Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion